With a strong international presence in over 75 countries and a commitment to continuous innovation, SMT offers a broad portfolio of medical devices including drug eluting stents, bare metal stents, balloon catheters, and inflation devices. Their aim is to expand their portfolio to comprehensively cover all facets of cardiovascular treatment support. SMT is dedicated to advancing patient care and saving lives with state-of-the-art medical devices, and they are proud to be the first company to secure a CE mark for biodegradable polymer-based drug eluting stents. Their philosophy is "PLEDGED TO SAVE MILLIONS."